Particle.news

Download on the App Store

OpenAI Accelerates Health Push With Instagram Product Leader and Doximity Cofounder

New leadership signals a pivot toward in-house health tools spanning clinical to consumer use.

Sam Altman, the CEO of OpenAI.

Overview

  • Ashley Alexander, formerly Instagram’s co-head of product, joined Tuesday as vice president of product for OpenAI’s health business to build tools for consumers and clinicians.
  • Nate Gross, Doximity’s cofounder and former chief strategy officer, is leading healthcare go-to-market efforts after joining in June with an early focus on co-creating tech with clinicians and researchers.
  • OpenAI is shifting from mainly powering partners to selling its own healthcare applications, leaning on GPT-5’s health performance and its HealthBench evaluation tool released in May.
  • The company will maintain collaborations, including a July study with Kenya’s Penda Health on an AI clinician copilot, and it continues to power startups such as Summer Health and Oscar Health.
  • The push enters a crowded field dominated by Palantir, Google, and Microsoft, while experts flag safety risks like error rates, automation bias, and opaque reasoning in clinical use.